Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To determine if the addition of monoclonal antibody to standard induction chemotherapy results in improved event free survival in patients with precursor B-cell ALL (aim 1B). To determine if the addition of nelarabine improves outcome for patients with T cell ALL (aim 1T)
Critère d'inclusion
- Acute lymphoblastic leukemia [ALL]